Please wait a minute...
 Home  About the Journal Editorial Board Aims & Scope Peer Review Policy Subscription Contact us
 
Early Edition  //  Current Issue  //  Open Special Issues  //  Archives  //  Most Read  //  Most Downloaded  //  Most Cited
Aging and disease    2016, Vol. 7 Issue (3) : 246-253     DOI: 10.14336/AD.2015.0925
Original Article |
Predictors of Difficulty in Medication Intake in Europe: a Cross-country Analysis Based on SHARE
Figueiredo Daniela1,2, Teixeira Laetitia3, Poveda Veronica3, Paúl Constança3,4, Santos-Silva Alice5, Costa Elísio5
1University of Aveiro, School of Health Sciences, Aveiro, Portugal.
2Center for Health Technology and Services Research (CINTESIS.UA), Aveiro, Portugal.
3Institute of Biomedical Sciences Abel Salazar, University of Porto, Porto, Portugal.
4CINTESIS, Center for Health Technology and Services Research (CINTESIS), Porto, Portugal.
5UCIBIO, REQUIMTE and Faculty of Pharmacy, University of Porto, Porto, Portugal.
Download: PDF(679 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks     Supporting Info
Guide   
Abstract  

The aim of this study is to evaluate the prevalence and the predictors of difficulty in medication intake across Europe, using a cross-sectional design. We used data from all participants in the wave 4 of the SHARE (Survey of Health, Ageing, and Retirement in Europe) database, which is a cross national European survey. The difficulty in take medication was evaluated using an item from the “Limitations with activities of daily living”. Clinical and sociodemographic variables were evaluated as potential predictors. A total of 58 124 individual have been included in this work (mean age=64.9 ± 10.4 years; 43.3% male). The rate of difficulty in taking medication across the 16 European evaluated countries was 2.1%, presenting Spain the highest rate (5.7%) and Switzerland the lowest (0.6%). Increasing age, physical inactivity, physical limitations (mobility, arms function and fine motor limitations, and difficulties in picking up a small coin from a table), a poor sense of meaning in life, and losses in memory and concentration are independent and significant variables associated with difficulty in medication intake across Europe. Predictors of difficulties in medication intake are multicausal, including factors related to physical, cognitive and psychological conditions. Interventions aiming to optimize adherence to medication, particularly in elderly population, need to consider this diversity of determinants.

Keywords difficulty in take medication      elderly      SHARE      non-adherence      persistence     
Corresponding Authors: Costa Elísio   
About author:

These authors equally contribute this work

Issue Date: 09 January 2016
Service
E-mail this article
E-mail Alert
RSS
Articles by authors
Figueiredo Daniela
Teixeira Laetitia
Poveda Veronica
Paúl Constança
Santos-Silva Alice
Costa Elísio
Cite this article:   
Figueiredo Daniela,Teixeira Laetitia,Poveda Veronica, et al. Predictors of Difficulty in Medication Intake in Europe: a Cross-country Analysis Based on SHARE[J]. Aging and disease, 2016, 7(3): 246-253.
URL:  
http://www.aginganddisease.org/EN/10.14336/AD.2015.0925     OR     http://www.aginganddisease.org/EN/Y2016/V7/I3/246
CountryAll individuals
(n)
Individuals with less than 65 years
(n)
Individuals with more than 65 years
(n)
Cases of difficulty in medication intake
All individuals
n (%)
Individuals with less than 65 years
n (%)
Individuals with more than 65 years
n (%)
Austria52412781245668 (1.3)8 (0.3)60 (2.4)
Germany157165391838 (2.4)3 (0.5)35 (3.8)
Sweden1946706124054 (2.8)1 (0.1)53 (4.3)
Netherlands27551503125226 (0.9)3 (0.2)23 (1.8)
Spain355516121943203 (5.7)30 (1.9)173 (8.9)
Italy35741736183895 (2.7)5 (0.3)90 (4.9)
France574731632581104 (1.8)16 (0.5)88 (3.4)
Denmark2269130696345 (2.0)4 (0.3)41 (4.3)
Switzerland37392052168721 (0.6)2 (0.1)19 (1.1)
Belgium527630862189108 (2.0)18 (0.6)90 (4.1)
Czechia607933562719100 (1.6)28 (0.8)72 (2.6)
Poland171794477264 (3.7)14 (1.5)50 (6.5)
Hungary30651773129153 (1.7)11 (0.6)4 (3.3)
Portugal2054115289846 (2.2)9 (0.8)37 (4.1)
Slovenia27411528121346 (1.7)13 (0.9)33 (2.7)
Estonia679532803515146 (2.1)26 (0.8)120 (3.4)
Total5812430440264491217 (2.1)191 (0.6)1026 (3.7)
Table 1  Distribution of the individuals from each country presenting difficulties in medication intake, and in accordance with age (less or more than 65 years).
nCases of difficulty in take medication
n (%)
Unadjusted
ORCI 95%p
Difficulties in walking 100 meters
Yes6986846 (12.1)1--
No51125368 (0.7)0.0530.047-0.060<0.001
Difficulties in picking up a small coin from a table
Yes2528660 (26.1)1--
No55583554 (1.0)0.0430.038-0.049<0.001
How satisfied with life56843827 (1.5)0.7130.692-0.734<0.001
Life has meaning
Never1690127 (7.5)1--
Rarely4189190 (4.5)0.5790.458-0.731<0.001
Sometimes13248244 (1.8)0.2280.183-0.286<0.001
Often37407254 (0.7)0.0860.06-0.108<0.001
Future looks good
Never4754317 (6.7)1--
Rarely11034236 (2.1)0.2860.240-0.341<0.001
Sometimes20335170 (0.8)0.1080.089-0.131<0.001
Often2017187 (0.4)0.0550.043-0.071<0.001
How many meals a day576611086 (1.9)1.1031.026-1.1850.008
Memory
Poor3900470 (12.1)1--
Fair11396259 (2.3)0.1220.105-0.143<0.001
Good25322176 (0.7)0.0440.037-0.053<0.001
Very good1337037 (0.3)0.0200.015-0.029<0.001
Excellent332417 (0.5)0.0280.017-0.045<0.001
Highest educational degree obtained37758684 (1.8)1.0091.006-1.012<0.001
Gender
Female32931701 (2.1)1--
Male25193516 (2.0)0.9530.849-1.0690.411
Network satisfaction54707849 (1.6)0.9020.860-0.946<0.001
Received help from others
No31799348 (1.1)1--
Yes8119433 (5.3)5.5474.815-6.452<0.001
Given help last twelve months
No29472733 (2.5)1--
Yes1044650 (0.5)0.1960.147-0.262<0.001
Number of chronic diseases580741214 (2.1)1.5351.492-1.580<0.001
Mobility, arm function and fine motor limitations581111214 (2.1)1.7741.736-1.814<0.001
Physical inactivity
Never vigorous nor moderate physical activity7188778 (10.8)1--
Other50482312 (0.6)0.0540.047-0.062<0.001
Sleep (part of EURO-D)
Selected20697518 (2.5)1--
Not selected36634451 (1.2)0.4970.437-0.565<0.001
Interest (part of EURO-D)
Selected5356362 (6.8)1--
Not selected51909576 (1.1)0.1670.146-0.192<0.001
Concentration (part of EURO-D)
Selected10826661 (6.1)1--
Not selected46374287 (0.6)0.0980.085-0.112<0.001
Enjoyment (part of EURO-D)
Selected8115417 (5.1)1--
Not selected49135516 (1.1)0.1980.173-0.226
Depression scale EURO-D - high is depressed56527838 (1.5)1.4691.434-1.504<0.001
Age581071217 (2.1)1.1181.111-1.124<0.001
Table 2  Association of explanatory variables with difficulty in medication intake (unadjusted models)
nCases of difficulty in take medication
n (%)
Adjusted
ORCI 95%p
Difficulties in picking up a small coin from a table
Yes2528660 (26.1)1--
No55583554 (1.0)0.4410.376-0.517<0.005
Life has meaning
Never1690127 (7.5)1--
Rarely4189190 (4.5)0.8350.663-1.0510.125
Sometimes13248244 (1.8)0.7510.608-0.9270.008
Often37407254 (0.7)0.7810.636-0.9600.019
Memory
Poor3900470 (12.1)1--
Fair11396259 (2.3)0.5300.454-0.618<0.001
Good25322176 (0.7)0.5310.455-0.620<0.001
Very good1337037 (0.3)0.5460.456-0.654<0.001
Excellent332417 (0.5)0.5550.440-0.701<0.001
Mobility, arm function and fine motor limitations581111214 (2.1)1.0741.051-1.097<0.001
Physical inactivity
Never vigorous nor moderate physical activity7188778 (10.8)1--
Other50482312 (0.6)0.6660.588-0.755<0.001
Concentration (part of EURO-D)
Selected10826661 (6.1)1--
Not selected46374287 (0.6)0.8220.736-0.918<0.001
Age581071217 (2.1)1.0051.001-1.0100.023
Table 3  Association of explanatory variables with difficulty in medication intake (adjusted model)
[1] Centers for Disease Control and Prevention (2003). Public Health and Aging: Trends in aging - United States and Worldwide. MMWR Weekly, 52:101-106.
[2] Roebuck M, Liberman J, Gemmill-Toyama M, Brennan T (2011). Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff, 30: 91-99.
[3] Bosworth H, Granger B, Mendys P, Brindis R, Burkholder R, Czajkowski S, Daniel J, Ekman I, Ho M, Johnson M, Kimmel S, Liu L, Musaus J, Shrank W, Buono E, Weiss K, Granger C (2011). Medication Adherence: A Call for Action. Am Heart J, 162:412-424.
[4] Sabaté E (2003). Adherence to long-term therapies: Evidence for action. WHO Library Cataloguing-in-Publication Data, Geneve.
[5] Nieuwlarr R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, Agoritsas T, Mistry N, Iorio A, Jack S, Sivaramalingam B, Iserman E, Mustafa R, Jedraszewski D, Cotoi C, R Haynes (2014). Interventions for enhancing medication adherence (Review). Cochrane Database Syst Rev, 11:CD000011.
[6] Dulmen S, Sluijs E, Dijk L, Ridder D, Heerdink R, Bensing J (2007). Patient adherence to medical treatment: A review of reviews. BMC Health Serv Res, 7:55.
[7] Krueger K, Berger B, Felkey B (2005). Medication adherence and persistence: A comprehensive review. Adv Ther, 22:313-356.
[8] Brown M, Brussell J (2011). Medication Adherence: WHO Cares? Mayo Clin Proc, 86:304-314.
[9] George J, Elliott R, Stewart D (2008). A sytematic review of interventions to improve medication taking in elderly patients prescribed multiple medications. Drugs Aging, 25: 307-324.
[10] Insel K, Morrow D, Brewer B, Figueiredo A (2006). Executive function, working memory, and medication adherence among older adults. J Gerontol B Psychol Sci Soc Sci, 61B: 102-107.
[11] Corsonello A, Pedone C, Lattanzio F, Lucchetti M, Garasto S, Carbone C, Greco C, Fabbietti P, Incalzi R (2009). Regimen complexity and medication nonadherence in elderly patients. Therapeutics and Clinical Risk Management, 5. 209-216.
[12] Alosco M, Spitznagel M, Dulmen M, Raz N, Cohen R, Sweet L, Colbert L, Josephson R, Hughes J, Rosneck J, Gunstad J (2012). Cognitive function and treatment adherence in older adults with heart failure. Psychosom Med, 79: 965-973.
[13] Goldney R, Fisher L (2005). Use of prescribed medications in a South Australian community sample. Med J Aust, 183:251-253.
[14] Elliott R (2006). Problems with medication use in the elderly: An Australian Perspective. Journal of Pharmacy Practice and Research, 36: 58-66.
[15] Hubbard R, O’Mahony M, Woodhouse K (2013). Medication prescribing in frail older people. Eur J Clin Pharmacol, 69: 319-326.
[16] Börsch-Supan A, Brandt M, Hunkler C, Kneip T, Korbmacher J, Malter F, Schaan B, Stuck S, Zuber S, SHARE Central Coordination Team (2013). Data Resource Profile: the Survey of Health, Ageing and Retirement in Europe (SHARE). Int J Epidemiol, 42: 992-1001.
[17] Malter F, Börsch-Supan A(Eds.) (2013). SHARE Wave 4: Innovations & Methodology, Munich: MEA, Max Planck Institute for Social Law and Social Policy.
[18] Jin J, Sklar GE, Min Sen V, Chuen Li S (2008). Factors affecting therapeutic compliance: A review from the patient’s perspective. Ther Clin Risk Manag, 4:269-286.
[19] Barkhof E, Meijer CJ, de Sonneville LM, Linszen DH, de Haan L (2012). Interventions to improve adherence to antipsychotic medication in patients with schizophrenia--a review of the past decade. Eur Psychiatry, 27: 9-18.
[20] Martin LR, Williams SL, Haskard KB, DiMatteo MR (2005). The challenge of patient adherence. Ther Clin Risk Manag, 3:189-199.
[21] Gray S, Mahoney J, Blough D (2001). Medication adherence in elderly patients receiving home health services following hospital discharge. Ann Pharmacother, 35:539-545.
[22] Vik S, Hogan D, Patten S, Johnson J, Romonko-Slack L, Maxwell C (2006). Medication nonadherence and subsequent risk of hospitalisation and mortality among older adults. Drugs Aging, 4: 345-356.
[23] Ruscin J, Semla T (1996). Assessment of medication management skills in older outpatients. Ann Pharmacother, 30:1083-1088.
[24] Krause N (2004). Stressors in highly valued roles, meaning in life, and the physical health status of older adults. J Gerontol B Psychol Sci Soc Sci, 59: S287-S297.
[25] Krause N (2009). Meaning in Life and Mortality. J Gerontol B Psychol Sci Soc Sci, 62: 517-527.
[26] Park C (2007). Religiousness/Spirituality and Health: A meaning systems perspective. J Behav Med: 319-328.
[27] De Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V, Car J, Atun R (2012). Mobile phone messaging for facilitation self-managment of long-term illness (Review). Cochrane Database Syst Rev, 12: CD007459.
[28] Mira J, Navarro I, Botella F, Borrás F, Nuño-Solinis R, Orozco D, Iglesias-Alonso F, Pérez-Pérez P, Lorenzo S, Toro N (2014). A Spanish Pillbox App for Elderly Patients Taking Multiple Medications: Randomized Controlled Trial. J Med Internet Res, 16: e99.
[29] Purdie M, Dunne M, Boyle F, Cook M, Najman J (2002). Health and demographic characteristics of respondents in an Australian national sexuality survey: Comparasion with population norms. J Epidemiol Community Health: 748-753.
[1] Binquan You, Bingbing Zhu, Xi Su, Feng Liu, Bingyin Wang. Gender Differences among Elderly Patients with Primary Percutaneous Coronary Intervention[J]. Aging and disease, 2018, 9(5): 852-860.
[2] da Rocha Erica Pires, Yokota Lais Gabriela, Sampaio Beatriz Motta, Cardoso Eid Karina Zanchetta, Dias Dayana Bitencourt, de Freitas Fernanda Moreira, Balbi Andre Luis, Ponce Daniela. Urinary Neutrophil Gelatinase-Associated Lipocalin Is Excellent Predictor of Acute Kidney Injury in Septic Elderly Patients[J]. Aging and disease, 2018, 9(2): 182-191.
[3] Wongrakpanich Supakanya, Wongrakpanich Amaraporn, Melhado Katie, Rangaswami Janani. A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly[J]. Aging and disease, 2018, 9(1): 143-150.
[4] Wongrakpanich Supakanya, Kallis Christos, Prasad Prithiv, Rangaswami Janani, Rosenzweig Andrew. The Study of Rhabdomyolysis in the Elderly: An Epidemiological Study and Single Center Experience[J]. Aging and disease, 2018, 9(1): 1-7.
[5] Tortorella Lucia, Vizzielli Giuseppe, Fusco Domenico, Cho William C., Bernabei Roberto, Scambia Giovanni, Colloca Giuseppe. Ovarian Cancer Management in the Oldest Old: Improving Outcomes and Tailoring Treatments[J]. Aging and disease, 2017, 8(5): 677-684.
[6] Garcovich Simone, Colloca Giuseppe, Sollena Pietro, Andrea Bellieni, Balducci Lodovico, Cho William C., Bernabei Roberto, Peris Ketty. Skin Cancer Epidemics in the Elderly as An Emerging Issue in Geriatric Oncology[J]. Aging and disease, 2017, 8(5): 643-661.
[7] Chojin Yasuo, Kato Tatsuji, Rikihisa Mariko, Omori Masami, Noguchi Shingo, Akata Kentaro, Ogoshi Takaaki, Yatera Kazuhiro, Mukae Hiroshi. Evaluation of the Mann Assessment of Swallowing Ability in Elderly Patients with Pneumonia[J]. Aging and disease, 2017, 8(4): 420-433.
[8] De Martinis Massimo, Sirufo Maria Maddalena, Ginaldi Lia. Allergy and Aging: An Old/New Emerging Health Issue[J]. Aging and disease, 2017, 8(2): 162-175.
[9] Su Jin Lee,Kyoung Min Kim,Eun Young Lee,Mi Kyung Song,Dae Ryong Kang,Hyeon Chang Kim,Yoosik Youm,Young Mi Yun,Hyun-Young Park,Chang Oh Kim,Yumie Rhee. Low Normal TSH levels are Associated with Impaired BMD and Hip Geometry in the Elderly[J]. A&D, 2016, 7(6): 734-743.
[10] Mihaela Vancea,Jordi Solé-Casals. Population Aging in the European Information Societies: Towards a Comprehensive Research Agenda in eHealth Innovations for Elderly[J]. A&D, 2016, 7(4): 526-539.
[11] Andrew T. Bates,Celia Divino. Laparoscopic Surgery in the Elderly: A Review of the Literature[J]. A&D, 2015, 6(2): 149-155.
[12] Kunlin Jin,James W. Simpkins,Xunming Ji,Miriam Leis,Ilia Stambler. The Critical Need to Promote Research of Aging and Aging-related Diseases to Improve Health and Longevity of the Elderly Population[J]. Aging and Disease, 2015, 6(1): 1-5.
[13] Kosaku Komiya,Hiroshi Ishii,Jun-ichi Kadota. Healthcare-associated Pneumonia and Aspiration Pneumonia[J]. Aging and Disease, 2015, 6(1): 27-37.
[14] Costa Elísio,Fernandes João,Ribeiro Sandra,Sereno José,Garrido Patrícia,Rocha-Pereira Petronila,Coimbra Susana,Catarino Cristina,Belo Luís,Bronze-da-Rocha Elsa,Vala Helena,Alves Rui,Reis Flávio,Santos-Silva Alice. Aging is Associated with Impaired Renal Function, INF-gamma Induced Inflammation and with Alterations in Iron Regulatory Proteins Gene Expression[J]. Aging and Disease, 2014, 5(6): 356-365.
[15] Natasa Radosavljevic,Dejan Nikolic,Milica Lazovic,Aleksandar Jeremic. Hip Fractures in a Geriatric Population - Rehabilitation Based on Patients Needs[J]. Aging and Disease, 2014, 5(3): 177-182.
Viewed
Full text


Abstract

Cited

  Shared   
Copyright © 2014 Aging and Disease, All Rights Reserved.
Address: Aging and Disease Editorial Office 3400 Camp Bowie Boulevard Fort Worth, TX76106 USA
Fax: (817) 735-0408 E-mail: editorial@aginganddisease.org
Powered by Beijing Magtech Co. Ltd